In The News

You are here

Dr. Souweidane’s Phase 1 Trial Findings Published in Lancet Oncology

Mark M Souweidane, MD, Weill Cornell Medicine

Today, the peer-reviewed journal Lancet Oncology published the highly anticipated results of Dr. Mark Souweidane’s first-ever dose escalation study using convection-enhanced delivery (CED) in patients with diffuse intrinsic pontine glioma (DIPG). The milestone Phase I clinical trial, which investigated the safety of using CED to bypass the blood-brain barrier and administer a drug directly to a brain stem tumor site, resulted in no serious adverse effects and no dose-limiting toxicity; researchers conclude that the technique is safe to use in children.

2018 Residency Graduation Celebrated; New Residents Welcomed

Drs. Peter Morgenstern, Philip E. Stieg, and Brenton Pennicooke

Peter Morgenstern, M.D., is continuing on to Seattle Children’s Hospital to complete a one-year pediatric neurosurgery fellowship; Dr. Brenton Pennicooke will spend his final year of training here at Weill Cornell Medicine in an enfolded fellowship in spine research.

2018 Neurosurgery Softball Tournament

As they do each year, on Saturday, June 9, 2018, the neurosurgeons of Weill Cornell Medicine participated in the annual Neurosurgery Charity Softball Tournament in Central Park. Founded in 2004, the tournament raises funds for brain tumor research.

Dr. Thomas Link Wins 2018 Apuzzo Award

Thomas Link, MD, and Michael LJ Apuzzo, MD

Fifth-year neurosurgical resident Thomas Link, MD, has been named the winner of the 2018 Michael L. J. Apuzzo Resident Literature Award for Creativity and Innovation.

Dr. Stieg Talks About the Effects of Marijuana on The Cats Roundtable

Dr. Philip Stieg, Weill Cornell Medicine

Dr. Stieg sits down with radio host John Catsimatidis about the effects of marijuana and any potential long-term effects it may have.

Pages